Story perspectives

Breakthrough Treatment Boosts Neuronal Health, Fights Alzheimer’s

8/21/2025

46 8

Summary

Story summary

Researchers at the University of California, Irvine discovered that nicotinamide and EGCG can restore GTP levels in neurons, potentially addressing brain aging and Alzheimer’s disease.
This treatment improved cellular cleanup and reduced toxic protein buildup, increasing neuronal viability by 22%.
GTP levels were found to decline with age, particularly in neurons modeled after Alzheimer’s.
Additional studies in live animals and human cells are needed to validate results and assess clinical applications.

1 of 1

Story summary

Researchers at the University of California, Irvine discovered that nicotinamide and EGCG can restore GTP levels in neurons, potentially addressing brain aging and Alzheimer’s disease.
This treatment improved cellular cleanup and reduced toxic protein buildup, increasing neuronal viability by 22%.
GTP levels were found to decline with age, particularly in neurons modeled after Alzheimer’s.
Additional studies in live animals and human cells are needed to validate results and assess clinical applications.